Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred O Mueck

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Medizinische Monatsschrift Fur Pharmazeuten|May 19, 2009
[Interactions between the 3-Month Syringe and antibiotics]Alfred O Mueck
Menopause (New York, N.Y.)|October 27, 2010
Exogenous hormones, the risk of venous thromboembolism, and activated protein C resistanceAlfred O Mueck
Medizinische Monatsschrift Fur Pharmazeuten|October 31, 2002
[Hormone replacement therapy and breast cancer]Alfred O Mueck
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Progestin effects in endometriosis treatment: new research on mechanismsAlfred O Mueck
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|May 26, 2017
Treatment of hyperandrogenism in women with ethinylestradiol and cyproteroneacetateAlfred O Mueck,
Therapeutische Umschau. Revue Therapeutique|September 24, 2021
[Clinical evaluation of progestogens used in Menopausal Hormone Therapy (MHT)]Alfred O Mueck
Gynakologisch-Geburtshilfliche Rundschau|October 28, 2006
[Hormone replacement therapy for internal risk patients]Alfred O Mueck
Arzneimittel-Forschung|February 26, 2004
Hormone therapy after endometrial cancerAlfred O Mueck, Harald Seeger
The Journal of Steroid Biochemistry and Molecular Biology|January 22, 2008
Are the progestins responsible for breast cancer risk during hormone therapy in the postmenopause? Experimental vs. clinical dataHarald Seeger, Alfred O Mueck
Menopause (New York, N.Y.)|January 10, 2008
Combination of hormone therapy with sartan: an option for hypertensive postmenopausal women?Alfred O Mueck, Harald Seeger
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Medizinische Monatsschrift Fur Pharmazeuten|May 19, 2009
[Interactions between the 3-Month Syringe and antibiotics]Alfred O Mueck
Menopause (New York, N.Y.)|October 27, 2010
Exogenous hormones, the risk of venous thromboembolism, and activated protein C resistanceAlfred O Mueck
Medizinische Monatsschrift Fur Pharmazeuten|October 31, 2002
[Hormone replacement therapy and breast cancer]Alfred O Mueck
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Progestin effects in endometriosis treatment: new research on mechanismsAlfred O Mueck
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|May 26, 2017
Treatment of hyperandrogenism in women with ethinylestradiol and cyproteroneacetateAlfred O Mueck,
Therapeutische Umschau. Revue Therapeutique|September 24, 2021
[Clinical evaluation of progestogens used in Menopausal Hormone Therapy (MHT)]Alfred O Mueck
Gynakologisch-Geburtshilfliche Rundschau|October 28, 2006
[Hormone replacement therapy for internal risk patients]Alfred O Mueck
Arzneimittel-Forschung|February 26, 2004
Hormone therapy after endometrial cancerAlfred O Mueck, Harald Seeger
The Journal of Steroid Biochemistry and Molecular Biology|January 22, 2008
Are the progestins responsible for breast cancer risk during hormone therapy in the postmenopause? Experimental vs. clinical dataHarald Seeger, Alfred O Mueck
Menopause (New York, N.Y.)|January 10, 2008
Combination of hormone therapy with sartan: an option for hypertensive postmenopausal women?Alfred O Mueck, Harald Seeger
Pageof 15